"In Type 1 and Type 2 diabetes, RT-CGM lowered HbA1c, improved time spent within the target glucose range (70–180 mg/dL), and reduced episodes of hypoglycemia in T1D and hypergl ...

Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of ...

Time in Range (TIR), a new statistic introduced by CGM systems. It measures how long a person's blood glucose levels remain within a particular range. According to Professor Kar, TIR provides "a ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Polsky said studies have found pregnant women with type 1 diabetes using CGM have higher maternal time in range and lower risk for neonatal adverse events than women performing self-monitoring ...

For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the inci ...

The following is a summary of “Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Researchers using continuous glucose monitoring uncover how your bedtime habits and sleep length directly affect your blood ...